Home > Healthcare > Analytical Instruments > Molecular Analysis > Molecular Cytogenetics Market

Molecular Cytogenetics Market Share

Report ID: GMI8693
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Molecular Cytogenetics Market Share

The molecular cytogenetics industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Molecular Cytogenetics Market Companies

Some of the eminent market participants operating in the molecular cytogenetics industry include:

Abbott Laboratories
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
BioView Ltd.
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
MetaSystems
PerkinElmer, Inc.
Sysmex Corporation

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global molecular cytogenetics industry was valued at around USD 2.5 billion in 2023 and is estimated to reach over USD 5.9 billion by 2032, owing to a significant increase in the prevalence of genetic disorders and cancer globally, fueled by factors such as aging populations, lifestyle changes, and environmental factors.

The comparative genomic hybridization (CGH) segment held a substantial revenue share worth USD 978.3 million in 2023, owing to its ability to detect chromosomal imbalances and copy number variations across the entire genome, with benefits such as high sensitivity, specificity, and resolution.

In 2023, North America held a significant share of 40.8% in the molecular cytogenetics market and is predicted to witness substantial growth through 2032, backed by the advanced healthcare infrastructure, coupled with continuous technological advancements and high healthcare expenditure.

Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioView Ltd., Danaher Corporation, F. Hoffmann-La Roche Ltd., Illumina, Inc., MetaSystems, PerkinElmer, Inc., and Sysmex Corporation among others.